CA9 and cancer: In the course of our research, devoted to discovering novel chemotypes acting as selective CA IX/XII inhibitors that could be employed in cancer chemotherapy, we previously designed and synthesised a series of 3H-1,2-benzoxaphosphepine 2-oxides as bioisosteres of homosulfocoumarins.19